Actively Recruiting

Phase Not Applicable
Age: 3Years - 18Years
All Genders
NCT06033183

Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology

Led by Neolys · Updated on 2024-11-22

100

Participants Needed

2

Research Sites

204 weeks

Total Duration

On this page

Sponsors

N

Neolys

Lead Sponsor

C

Centre Francois Baclesse

Collaborating Sponsor

AI-Summary

What this Trial Is About

Analysis of the individual radiosensitivity in pediatric oncology

CONDITIONS

Official Title

Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology

Who Can Participate

Age: 3Years - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Minor patient treated for a brain tumor, Ewing tumor, malignant mesenchymal tumor, neuroblastoma, nephroblastoma, Hodgkin's lymphoma treated with radiotherapy (+/- chemotherapy) for curative purposes
  • Children or adolescents older than 3 years and younger than 18 years
  • Patient with an indication for radiotherapy as part of the primary tumor local control strategy
  • Theoretical indication for radiotherapy in standard fractionation (1.8 Gy to 2.2 Gy per fraction; 5 fractions per week), regardless of technique or particle used
  • Patient affiliated with a social security scheme
  • Patient and/or parents or holders of parental authority having dated and signed an informed consent
Not Eligible

You will not qualify if you...

  • Patients with contraindications to blood sampling
  • Patients with contraindications to radiotherapy
  • Patients receiving palliative radiotherapy
  • Patients with previous radiotherapy treatment in the same area (re-irradiation)
  • Patients indicated for hypofractionated radiotherapy
  • Patients for whom follow-up is not possible
  • Persons deprived of liberty or under guardianship (including curatorship)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Centre François Baclesse

Caen, France

Actively Recruiting

2

Centre Oscar Lambret

Lille, France

Not Yet Recruiting

Loading map...

Research Team

S

Sandrine PEREIRA, PhD

CONTACT

J

Jennifer RUOS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SCREENING

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here